ZOLI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 34.168
AS - Asia 17.973
EU - Europa 17.368
SA - Sud America 2.483
AF - Africa 350
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 24
Totale 72.415
Nazione #
US - Stati Uniti d'America 33.530
SG - Singapore 5.780
GB - Regno Unito 5.621
CN - Cina 4.978
DE - Germania 3.425
IT - Italia 3.073
HK - Hong Kong 1.936
BR - Brasile 1.897
VN - Vietnam 1.680
SE - Svezia 1.361
RU - Federazione Russa 930
FI - Finlandia 790
BD - Bangladesh 751
KR - Corea 748
TR - Turchia 714
UA - Ucraina 676
FR - Francia 479
CA - Canada 346
IN - India 301
BG - Bulgaria 267
AR - Argentina 217
ID - Indonesia 180
MX - Messico 157
IQ - Iraq 126
NL - Olanda 125
ZA - Sudafrica 117
JP - Giappone 113
EC - Ecuador 83
ES - Italia 82
PL - Polonia 77
IE - Irlanda 74
CO - Colombia 72
AE - Emirati Arabi Uniti 71
PK - Pakistan 71
MY - Malesia 70
BE - Belgio 63
CL - Cile 57
PH - Filippine 56
VE - Venezuela 52
AT - Austria 47
AU - Australia 46
LT - Lituania 46
UZ - Uzbekistan 43
MA - Marocco 42
PY - Paraguay 42
TH - Thailandia 41
IR - Iran 40
RO - Romania 39
KE - Kenya 36
DZ - Algeria 33
JO - Giordania 33
SA - Arabia Saudita 32
IL - Israele 30
TN - Tunisia 28
UY - Uruguay 27
CH - Svizzera 26
EG - Egitto 24
AZ - Azerbaigian 23
CZ - Repubblica Ceca 23
NP - Nepal 20
DO - Repubblica Dominicana 19
EU - Europa 19
PE - Perù 19
AL - Albania 18
AN - Antille olandesi 18
CR - Costa Rica 18
ET - Etiopia 17
KZ - Kazakistan 17
LB - Libano 17
OM - Oman 16
PT - Portogallo 16
RS - Serbia 16
TW - Taiwan 16
BO - Bolivia 15
BH - Bahrain 13
GE - Georgia 13
PA - Panama 13
DK - Danimarca 12
JM - Giamaica 12
NO - Norvegia 11
BY - Bielorussia 9
HU - Ungheria 9
PR - Porto Rico 9
SN - Senegal 9
HN - Honduras 8
NG - Nigeria 8
TT - Trinidad e Tobago 8
CU - Cuba 7
GR - Grecia 7
KG - Kirghizistan 7
LU - Lussemburgo 7
LV - Lettonia 7
AO - Angola 6
NI - Nicaragua 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
AM - Armenia 5
CI - Costa d'Avorio 5
GT - Guatemala 5
Totale 72.322
Città #
Southend 4.246
Ashburn 3.206
Fairfield 3.120
Santa Clara 2.997
Singapore 2.902
Hefei 2.331
Woodbridge 2.104
Chandler 1.981
Hong Kong 1.908
Houston 1.804
Jacksonville 1.351
Ann Arbor 1.105
Seattle 1.097
Wilmington 1.072
Dearborn 1.013
Cambridge 978
Chicago 942
San Jose 884
Nyköping 810
Seoul 708
Beijing 699
London 679
Los Angeles 626
Council Bluffs 587
Ho Chi Minh City 548
Helsinki 541
Modena 526
The Dalles 451
Como 429
Izmir 403
Hanoi 384
New York 369
Buffalo 309
Princeton 300
San Diego 296
Milan 276
Sofia 257
Eugene 231
Lauterbourg 212
Moscow 163
São Paulo 161
Columbus 156
Munich 152
Shanghai 143
Des Moines 139
Salt Lake City 139
Redwood City 129
Dallas 122
Jakarta 109
Bologna 106
Orem 106
Rome 102
Falls Church 97
Tokyo 88
Toronto 84
Ottawa 82
Da Nang 75
Boardman 74
Frankfurt am Main 73
Guangzhou 70
Elk Grove Village 68
Johannesburg 68
Kocaeli 67
Philadelphia 67
Atlanta 64
Haiphong 64
Tampa 64
Chennai 63
Dublin 63
Kent 61
Phoenix 61
Brooklyn 59
Norwalk 59
Warsaw 57
Rio de Janeiro 56
Brussels 55
Mexico City 55
Montreal 53
Bremen 51
Tulare 49
Baghdad 47
Miano 46
Stockholm 46
Amsterdam 42
Belo Horizonte 42
Brasília 41
Vancouver 39
Nanjing 38
Redondo Beach 38
Tashkent 38
Kunming 36
Nuremberg 36
San Francisco 36
Falkenstein 35
Manchester 35
Naples 34
Quito 33
Fremont 32
Porto Alegre 32
Nairobi 31
Totale 49.013
Nome #
Neuroscienze e libero arbitrio 681
D2R–striatopallidal neurons inhibit both locomotor and drug reward processes 442
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 441
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 427
7-Chloro-5-(furan-3-yl)-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-Dioxide as Positive Allosteric Modulator of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor. The End of the Unsaturated-Inactive Paradigm? 407
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 398
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: Design, synthesis and pharmacological characterization 392
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 381
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice 378
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats 368
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 368
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 367
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 367
Heterogeneity and complexity of native brain nicotinic receptors 366
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 365
Specific Dopamine Sensing Based on Short-Term Plasticity Behavior of a Whole Organic Artificial Synapse 365
Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function. 364
Developmental overfeeding alters hypothalamic neuropeptide mRNA levels and response to a high-fat diet in adult mice 364
Age-related alterations in tanycytes of the mediobasal hypothalamus of the male rat 360
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 360
Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period 359
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 359
Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum. 357
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice 357
Wiring and volume transmission in the central nervous system: The concept of closed and open synapses 356
Exploiting interfacial phenomena in organic bioelectronics: Conformable devices for bidirectional communication with living systems 354
Loss of high-affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment 353
Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice 351
Whole organic electronic synapses for dopamine detection 349
Diet-induced changes in hypothalamic pro-opio-melanocortin mRNA in the rat hypothalamus 348
Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum 348
Effects of neurotoxic and mechanical lesions of the mesostriatal dopamine pathway on striatal polyamine levels in the rat: modulation by chronic ganglioside GM1 treatment. 348
Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate. 343
Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides. 342
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. 341
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 341
Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors 340
The emergence of the volume transmission concept 337
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 336
Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections 335
Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats. 335
Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice 335
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 334
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes 331
Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments 330
Cellular and synaptic alterations in the aging brain. 328
Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats 328
Simultaneous measurement of adenosine, dopamine, acetylcholine and 5-hydroxytryptamine in cerebral mice microdialysis samples by LC–ESI-MS/MS 328
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 327
Intercellular communication in the brain: Wiring versus volume transmission 326
Degenerazione e rigenerazione nel sistema nervoso centrale: rilevanza dei fattori trofici e della trasmissione neuronale colinergica nel trofismo del sistema nervoso centrale. 326
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 324
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain 322
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. 322
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice 320
D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release. 320
Regional and cellular distribution of spermidine/spermine N-1-acetyltransferase (SSAT) mRNA in the rat central nervous system 319
A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. 319
Diversity of native nicotinic receptor subtypes in mammalian brain 318
In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 318
"Heart-cut" bidimensional achiral-chiral liquid chromatography applied to the evaluation of stereoselective metabolism, in vivo biological activity and brain response to chiral drug candidates targeting the central nervous system 317
Spermidine/spermine N-1-acetyltransferase mRNA levels show marked and region-specific changes in the early phase after transient forebrain ischemia 317
Nicotine and neurodegeneration in ageing 316
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the rat. 316
Neuromorphic Organic Devices that Specifically Discriminate Dopamine from Its Metabolites by Nonspecific Interactions 316
A single (-)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra. 315
Corticosterone treatment counteracts lesions induced by neonatal treatment with monosodium glutamate in the mediobasal hypothalamus of the male rat 314
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 314
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
MicroRNA-101 Regulates Multiple Developmental Programs to Constrain Excitation in Adult Neural Networks 312
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL NERVOUS SYSTEM .7. THEORETICAL ASPECTS OF BRAIN COMMUNICATION AND COMPUTATION 312
SELECTIVE REDUCTION OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVITY IN THE HIPPOCAMPAL-FORMATION AND CENTRAL AMYGDALOID NUCLEUS OF THE AGED RAT 311
Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence. 311
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 311
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL NERVOUS SYSTEM .5. STUDIES ON A MODEL OF TRANSIENT FOREBRAIN ISCHEMIA IN MALE SPRAGUE-DAWLEY RATS 310
Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats 308
Changes in nicotinic acetylcholine receptor subunit mRNAs and nicotinic binding in spontaneously hypertensive stroke prone rats 308
Nicotine withdrawal increases body weight, neuropeptide Y and Agouti-related protein expression in the hypothalamus and decreases uncoupling protein-3 expression in the brown adipose tissue in high-fat fed mice 308
Exposure to an enriched environment selectively increases the functional response of the pre-synaptic NMDA receptors which modulate noradrenaline release in mouse hippocampus 306
Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat 304
The receptor mosaic hypothesis of the engram: Possible relevance of Boolean network modeling 304
An improved LC-S/MS method for the quantitation of adenosine concentration in mice brain microdialysates 304
Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive nerve terminals and on glucocorticoid receptor-immunoreactive nerve cell nuclei in the paraventricular hypothalamic nucleus in adult and old male rats. 304
Structural and functional diversity of native brain neuronal nicotinic receptors 303
Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. 303
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .6. STUDIES OF THE EFFECTS OF GANGLIOSIDES ON BRAIN METABOLIC LESIONS 302
Pharmacological manipulation of brain galaninergic system and sexual behavior in male mice 302
Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia 302
A NEW MODEL OF FOCAL BRAIN ISCHEMIA BASED ON THE INTRACEREBRAL INJECTION OF ENDOTHELIN-1 302
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 301
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .1. COMPUTER-ASSISTED IMAGE-ANALYSIS METHODS 300
Brain nicotinic acetylcholine receptors: native subtypes and their relevance 300
MAPPING AND COMPUTER-ASSISTED MORPHOMETRY AND MICRODENSITOMETRY OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVE NEURONS AND GLIAL-CELLS IN THE RAT CENTRAL-NERVOUS-SYSTEM 298
Volume transmission in the CNS and its relevance for neuropsychopharmacology 298
Protective effects of delapril combined with indapamide or hydrochlorothiazide in spontaneously hypertensive stroke-prone rats: a comparative dose-response analysis 298
Neuron-glia cross talk in rat striatum after transient forebrain ischemia 297
Intravenous uridine treatment antagonizes hypoglycaemia-induced reduction in brain somatostatin-like immunoreactivity. 296
DAT atypical inhibitors as novel antipsychotic drugs 296
Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner 295
Totale 33.806
Categoria #
all - tutte 265.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 265.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 0 0 0 0 0 0 275
2021/20225.148 124 622 521 308 137 227 315 296 571 370 942 715
2022/20234.947 649 629 461 427 543 724 73 474 585 45 208 129
2023/20242.759 121 190 322 262 534 270 189 322 67 61 121 300
2024/202513.151 638 115 147 815 2.098 1.595 957 682 1.073 1.292 2.130 1.609
2025/202621.688 1.794 1.154 1.958 2.110 2.585 1.656 2.203 1.225 2.377 1.942 1.434 1.250
Totale 72.795